摘要
Objective: To investigate the relationship between estrogen receptor(ER) gene and the clinical indexes associated with coronary heart disease (CHD). Methods: By means of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), we analyzed ER gene polymorphism in 84 CHD patients and 61 healthy subjects and non-CHD inpatients. The clinical indexes associated with CHD were analyzed in relation to the three ER genotypes. Results: There were significant differences in the incidence of hypertension (58.62%), fibrinogen (Fib) concentration (3.5±0.8 g/L), body mass index (BMI, 25.1±3.2), HDL-C concentration (1.0±0.2 mmol/L) between PP genotype group and other genotype groups (P<0.05). Conclusion: ER gene polymorphism may affect ER-mediated cardiovascular protective effect by modulating the expression of ER.
Objective: To investigate the relationship between estrogen receptor (ER) gene and the clinical indexes associated with coronary heart disease ( CHD). Methods: By means of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) , we analyzed ER gene polymorphism in 84 CHD patients and 61 healthy subjects and non-CHD inpatients. The clinical indexes associated with CHD were analyzed in relation to the three ER genotypes. Results: There were significant differences in the incidence of hypertension (58.62% ), fibrinogen (Fib) concentration (3. 5±0. 8 g/L) , body mass index (BMI, 25. 1±3. 2) , HDL-C concentration (1.0±0. 2 mmol/L) between PP genotype group and other genotype groups (P <0. 05). Conclusion: ER gene polymorphism may affect ER-mediated cardiovascular protective effect by modulating the expression of ER.
基金
Supported by the Key Basic Research and Development Project of National "973" Program of China (G200057008)
the Foundation for University Leading Teachers Sponsored by the Ministry of Education of China, and by Funds for Key Natural Science Research of
